방부제 및 소독제 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 제품별, 최종 용도별, 판매채널별, 지역별, 부문별 예측(2024-2030년)

Antiseptic And Disinfectant Market Growth & Trends:

The global antiseptic and disinfectant market size is anticipated to reach USD 63.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.8% from 2024 to 2030. Key factors driving the market expansion include technological advancements in antiseptics and disinfectants along with increasing use of endoscope reprocessors and surgical units. The current COVID-19 outbreak is expected to have a substantial impact on the market. The pandemic has resulted in a significant surge in demand for emergency supplies, hospital equipment, medicines, and medical disposables. According to Eurostat in 2020, extra-EU exports and imports of COVID-19 related products increased by 5.5 % and 10.4 % respectively, compared to 2019.

Additionally, EU extra- imports of protective oxygen and garments equipment recorded the highest increase (respectively by 38.7% and 40.3 % compared with 2019) amongst COVID-19 related products, followed by sterilization products (19.1 %) and. diagnostic equipment (19.2 %). However, the highest increases for EU- extra- exports were recorded for diagnostic testing equipment (14.9%), and sterilization products (16.0 %). As a result, market growth is expected to accelerate in the near future. Furthermore, the global market for antiseptics and disinfectants is consolidating due to the rising popularity of medical equipment along with the increased research collaboration and agreements between diverse manufacturers. For instance, in June 2021, Bactiguard and Schulke & Mayr GmbH, a German company, agreed to distribute Bactiguard's wound care solutions exclusively to German hospitals. The agreement allows schulke to add Bactiguard's hypochlorous acid-based portfolio to its existing antiseptic and wound-care product line which will, in turn, push the market scale during the study period.

Antiseptic And Disinfectant Market Report Highlights:

• In terms of revenue, the quaternary ammonium compounds held the largest share of around 31.4% in 2023, owing to the rising incidence of healthcare-associated infections and the increasing number of hospitals across the globe
• The enzymatic cleaners segment is expected to witness the fastest CAGR of 10.5% over the forecast period. The growth of this segment can be attributed to the increasing number of hospitals in developing countries
• The hospital segment is expected to witness the fastest growth rate of 10.6% over the forecast period. The increasing number of hospitals in developing countries is expected to propel segment growth
• In terms of revenue, the B2B segment held the largest share owing to the rising end-users opting for this sales channel across the globe
• In Asia Pacific, the market is expected to witness the fastest CAGR of 11.5% over the forecast period, owing to the rising prevalence of cardiovascular, neurology, and urology disorders

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product
  • 1.2.3. Sales
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Product outlook
  • 2.2.3. Sales outlook
  • 2.2.4. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Antiseptic and Disinfectant Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Hospital-acquired Infections
    • 3.2.1.2. Growing Awareness About Home Cleanliness
    • 3.2.1.3. Increasing Use of Endoscope Reprocessors and Surgical Units
    • 3.2.1.4. Impact Of Covid-19
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulations Pertaining to Usage of Antiseptics & Disinfectants
• 3.3. Antiseptic and Disinfectant Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. Bargaining power of suppliers
  • 3.3.3. Bargaining power of buyers
  • 3.3.4. Threat of substitutes
  • 3.3.5. Threat of new entrants
  • 3.3.6. Competitive rivalry
  • 3.3.7. PESTEL Analysis
    • 3.3.7.1. Political landscape
    • 3.3.7.2. Economic landscape
    • 3.3.7.3. Social landscape
    • 3.3.7.4. Technological landscape
    • 3.3.7.5. Environmental landscape
    • 3.3.7.6. Legal landscape

Chapter 4. Antiseptic and Disinfectant Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Antiseptic and Disinfectant Market: Type Movement Analysis
• 4.3. Antiseptic and Disinfectant Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Quaternary Ammonium Compounds
  • 4.5.1. Quaternary Ammonium Compounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Chlorine Compounds
  • 4.6.1. Chlorine Compounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Alcohols & Aldehyde Products
  • 4.7.1. Alcohols & Aldehyde Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Enzyme
  • 4.8.1. Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Antiseptic and Disinfectant Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Antiseptic and Disinfectant Market: Product Movement Analysis
• 5.3. Antiseptic and Disinfectant Market by Product Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Enzymatic Cleaners
  • 5.5.1. Enzymatic Cleaners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Medical Device Disinfectants
  • 5.6.1. Medical Device Disinfectants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Surface Disinfectants
  • 5.7.1. Surface Disinfectants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Antiseptic and Disinfectant Market: Sales Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Antiseptic and Disinfectant Market: Sales Movement Analysis
• 6.3. Antiseptic and Disinfectant Market by Sales Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. B2B
  • 6.5.1. B2B Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. FMCG
  • 6.6.1. FMCG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Antiseptic and Disinfectant Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Antiseptic and Disinfectant Market: End-use Movement Analysis
• 7.3. Antiseptic and Disinfectant Market by End-use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Clinics
  • 7.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Antiseptic and Disinfectant Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Antiseptic and Disinfectant Market movement analysis
• 8.3. Antiseptic and Disinfectant Market: Regional Estimates & Trend Analysis by Type, Product, Sales & End-use
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. North America
  • 8.5.1. North America Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Europe
  • 8.5.6. Europe Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. UK
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. UK Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Germany
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Germany Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. France
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. France Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Italy
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Reimbursement scenario
    • 8.5.10.5. Italy Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Spain
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Reimbursement scenario
    • 8.5.11.5. Spain Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.12. Denmark
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Reimbursement scenario
    • 8.5.12.5. Denmark Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.13. Sweden
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Reimbursement scenario
    • 8.5.13.5. Sweden Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.14. Norway
    • 8.5.14.1. Key Country Dynamics
    • 8.5.14.2. Competitive Scenario
    • 8.5.14.3. Regulatory Framework
    • 8.5.14.4. Reimbursement scenario
    • 8.5.14.5. Norway Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Japan Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. China Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. India Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. South Korea Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Australia Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Thailand Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Brazil Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Argentina Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. South Africa Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Saudi Arabia Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. UAE Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Kuwait Antiseptic and Disinfectant Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Antiseptic and Disinfectant Market: Regional Estimates & Trend Analysis

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
  • 9.2.1. Innovators
  • 9.2.2. Market Leaders
• 9.3. Vendor Landscape
  • 9.3.1. Key Company Market Share Analysis, 2023
  • 9.3.2. Major Deals & Strategic Alliances
    • 9.3.2.1. New Product Launch
    • 9.3.2.2. Expansion
    • 9.3.2.3. Acquisition
• 9.4. Company Profiles
  • 9.4.1. 3M
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Benchmarking
    • 9.4.1.3. Financial Performance
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Reckitt Benckiser
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Benchmarking
    • 9.4.2.3. Financial Performance
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Steris Plc
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Benchmarking
    • 9.4.3.3. Financial Performance
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. KIMBERLY-CLARK CORPORATION
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Benchmarking
    • 9.4.4.3. Financial Performance
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. BIO-CIDE INTERNATIONAL
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Benchmarking
    • 9.4.5.3. Financial Performance
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. CARDINAL HEALTH
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Benchmarking
    • 9.4.6.3. Financial Performance
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. BD
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Benchmarking
    • 9.4.7.3. Financial Performance
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Johnson & Johnson
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Benchmarking
    • 9.4.8.3. Financial Performance
    • 9.4.8.4. Strategic Initiatives